Status:
COMPLETED
A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in Greece
Lead Sponsor:
AstraZeneca
Conditions:
Hyperkalaemia
Eligibility:
All Genders
18-100 years
Brief Summary
This is a multicenter, observational, prospective, national study which includes patients with chronic kidney disease (CKD) under dialysis or not, or with heart failure (HF), treated with sodium zirco...
Eligibility Criteria
Inclusion
- Signed Informed Consent Form.
- Older than 18 years at the time of consent.
- Treated with sodium zirconium cyclosilicate (SZC) for hyperkalaemia at the time of enrolment, and having started receiving sodium zirconium cyclosilicate (SZC) at least 10 days before enrolment.
- Patients diagnosed with hyperkalaemia (Serum Potassium (S-K)+ \>5.0 mmol/L), and with chronic kidney disease (CKD) not on dialysis (Group 1) or on dialysis (Group 2), or with heart failure (HF), receiving Renin angiotensin aldosterone inhibitors/Mineralocorticoid receptor antagonists (RAASi/MRAs) therapy (Group 3).
Exclusion
- Patients who are pregnant, breast-feeding, or planning to become pregnant.
- Patients already participating in another clinical trial.
- Presence of a condition that, in the opinion of the investigator: i) would put the subject at undue risk, or ii) would potentially jeopardize the quality of the data to be generated, or iii) would, for some other reason, make the patient inappropriate for this study.
Key Trial Info
Start Date :
February 9 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 3 2025
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT06185660
Start Date
February 9 2024
End Date
January 3 2025
Last Update
December 30 2025
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Alexandroupoli, Greece, 68100
2
Research Site
Athens, Greece, 10676
3
Research Site
Athens, Greece, 11527
4
Research Site
Athens, Greece, 12462